This site is intended for healthcare professionals only
LoginRegister
Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology DealMerck Enflonsia wins ACIP backing for RSV protection in infants under 8 months
Intas PharmaIntas Gets SEC Nod to Import, Market Anti-Cancer Drug Serplulimab, Phase IV Trial Mandated
Bristol Myers Squibb Breyanzi secures European Commission nod for Mantle Cell LymphomaUSFDA approves label updates for Bristol Myers Squibb 2 CAR T cell therapies
Bayer new drug application for gadoquatrane accepted for review in ChinaBayer Eylea 8 mg with extended 6-month treatment interval approved in EU for retinal diseases
Abbott Volt Pulsed Field Ablation System bags USFDA approval for atrial fibrillationAbbott Gets SEC Nod to Market Chlordiazepoxide Tablets for Anxiety, Alcohol Withdrawal
USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas PharmaPfizer Gets CDSCO Panel Nod to Conduct Phase IIIb Trial of Rimegepant for Menstrual Migraine
Sun Pharma unit Taro recalls over 17k units of antifungal medication in USSafety first: Aurobindo recalls discolored pain relieving drug in US
Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance FailuresUSFDA lifts Risk Evaluation and Mitigation Strategies for CAR T cell therapies
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsUSFDA issues 1 observation for Granules Pharma USA facility
Breaking News: Health Ministry Bans Immediate-Release Nimesulide Oral Doses Above 100 mg14 Drugs Including Pomol-650, Glimiz-2 Banned in Karnataka, Check Full List
Akums Drugs Secures EU-GMP Certification for Two Haridwar PlantsAkums Gets CDSCO Panel Nod for BE Study of Rizatriptan-Meloxicam FDC, Told to Revise Phase III...
CDSCO Asks Serum Institute to Revise Protocol for Trivalent Flu-COVID Vaccine TrialCDSCO Asks Serum Institute to Revise Protocol for Trivalent Flu-COVID Vaccine Trial
X